Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Market Cap	5.94B
Revenue (ttm)	301.21M
Net Income (ttm)	16.14M
Shares Out	113.55M
EPS (ttm)	0.14
PE Ratio	367.97
Forward PE	80.48
Dividend	0.42 (0.80%)
Ex-Dividend Date	May 23, 2025

Volume	1,436,773
Average Volume	1,767,289
Open	52.28
Previous Close	52.28
Day's Range	52.00 - 53.51
52-Week Range	24.50 - 56.33
Beta	0.61
RSI	66.44
Earnings Date	Aug 23, 2025

About Shanghai OPM Biosciences

Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers OPM cell culture media services, including OPM-CHO platform, OPM-293 platform, OPM-VAC platform, OPM-Hybri platform, and classical media; customized media solutions; and OEM media manufacturing services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development & cell banking platform, upstream process development, downstream process development, OPM formulation dev...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 328
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688293

Financial Performance

In 2024, Shanghai OPM Biosciences's revenue was 297.24 million, an increase of 22.26% compared to the previous year's 243.12 million. Earnings were 21.05 million, a decrease of -61.04%.